ArticlePharmaceutics2022

Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study.

Martina Tallarico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.